Navigation Links
BMP Sunstone Reiterates Commitment to Quality, Innovation and Long-Term Growth at Meeting with Senior Officials
Date:2/17/2009

PLYMOUTH MEETING, Pa., Feb. 17 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP) (''BMP Sunstone'' or the ''Company'') announced today that on February 8, 2009, senior executives of Sunstone (Tangshan) Pharmaceutical Co., Ltd., hosted a visit by Zhang Dejiang, the Vice Premier of the State Counsel of the PRC, as well by the head of Hebei provincial government and other senior central and local government officials. During the visit, the Company reaffirmed its dedication to quality, innovation, and long-term growth.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090217/CNTU049 )

Mr. Zhiqiang Han, General Manager and Chairman of the Board of Sunstone, commented, ''As a leading pharmaceutical company in China, with one of the largest granulation facilities in the country, and with a robust product portfolio including Hao Wawa, awarded national brand status in China, we were included in the Vice Premier's recent visit to the region. We are honored and encouraged by this opportunity to represent China's evolving healthcare industry.''

Han continued, ''During the visit, we reiterated our commitment to stringent quality control and innovation, as well as to financial strength. Our dedication to quality and safety is reflected in our ongoing brand leadership, especially in pediatrics and women's health. We have consistently sought to invest in research and development so that we enhance our product offering and have the potential to drive long-term growth. We also remain focused on delivering the best service to our customers as well as enhanced financial performance for our shareholders.''

About BMP Sunstone Corporation

BMP Sunstone Corporation is a specialty pharmaceutical company that is building a proprietary portfolio of branded pharmaceutical and healthcare products in China. Currently this portfolio includes eight products under exclusive multi-year licenses for China, primarily focused on women's health and pediatrics. The Company also owns Sunstone Pharmaceutical Co. Ltd., which manufactures leading pediatric and women's health products, including two of China's most recognized brands, "Hao Wawa" and "Confort," sold through approximately 120,000 pharmacies in China. The Company also provides pharmaceutical distribution services through its subsidiaries in Beijing and Shanghai, and through its affiliate, Guangzhou Pharmaceuticals Corp. The Company has its main office in Beijing, with a US office in Plymouth Meeting, PA. For more information, please visit http://www.bmpsunstone.com .

Safe Harbor Statement

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts, including but not limited to statements about the Company's quality control, innovation and financial strength, the long-term prospects of the Company and the Company's intent and ability to enhance its capabilities and realized additional opportunities. These statements are subject to uncertainties and risks including, but not limited to, operating performance, general financial, economic, and political conditions affecting the biotechnology and pharmaceutical industries and the Chinese pharmaceutical market, the ability to timely manufacture and distribute the Company's products and other risks contained in reports filed by the Company with the Securities and Exchange Commission. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

    For more information, please contact:

     Integrated Corporate Relations, Inc.
     Ashley M. Ammon and Christine Duan
     Tel: +1-203-682-8200 (Investor Relations)

'/>"/>
SOURCE BMP Sunstone Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. BMP Sunstone Announces Exchange Offer of $10.7 Million of Outstanding Secured Notes
2. BMP Sunstone to Report Third Quarter 2008 Financial Results
3. BMP Sunstone Signs Letter of Intent to Acquire Shengda Pharmaceutical Co.
4. BMP Sunstone Completes Acquisition of Shanghai Rongheng Pharmaceutical Co., Ltd
5. BMP Sunstone Announces Official Launch of Ferriprox in PRC
6. BMP Sunstone Announces Participation in June Investor Conferences
7. BMP Sunstone Reports First Quarter 2008 Financial Results
8. BMP Sunstone Donates RMB 1.2 Million to Earthquake Relief
9. BMP Sunstone Announces Participation in May Investor Conferences
10. BMP Sunstone to Report First Quarter 2008 Financial Results
11. BMP Sunstones Propess(R) Recommended as First Line Treatment By the Chinese Medical Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based workplace ... Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored at ... from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located ...
(Date:10/12/2017)... ... , ... In the United States, single-family home owners pay ... York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the average is $7,000 a ... rates, which contributes to the relatively lower cost of living in places like ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Dining at the University of California Berkeley, and other leading institutions in announcing ... buying power of institutions to change the way animals are raised for food. ...
(Date:10/12/2017)... San Antonio, Texas (PRWEB) , ... October 12, ... ... medical device and biologics manufacturer, has expanded its executive staff with the addition ... Development. , In this role, Slott will develop the national distribution and sales ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Lilly and Company (NYSE: LLY ) will ... 2017 on Tuesday, October 24, 2017. Lilly will also ... investment community and media to further detail the company,s ... at 9 a.m. Eastern time. Investors, media and the ... conference call through a link that will be posted ...
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... AMSTERDAM , Sept. 25, 2017   ... Trial Master File solutions, today—from the IQPC Trial ... Amsterdam , NL)—announced that EastHORN Clinical Services ... its clinical programs and TMF management. EastHORN, a ... Montrium,s eTMF platform to increase transparency to enable ...
Breaking Medicine Technology: